Chemotherapy News and Research

Latest Chemotherapy News and Research

Important biomarker may help in determining prognosis of brain cancer patients

A common virus that is harmless to most individuals may produce an important biomarker in determining the prognosis of brain cancer patients, according to a recent study published by a student researcher at the University of Cincinnati.

9 Dec 2019

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients' bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

8 Dec 2019

Genetic features of AML in older patients can predict outcomes after stem cell transplant

For older patients with acute myeloid leukemia, the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute and other research centers will report today at the 61st American Society of Hematology (ASH) Annual Meeting.

8 Dec 2019

Cancer in the eye does not always develop into central nervous system lymphoma

Researchers at Okayama University report in the Journal of clinical and experimental hematopathology that primary intraocular lymphoma, a cancer in the eye, does not always develop into central nervous system lymphoma.

6 Dec 2019

$Novel agent opens up new treatment option for patients with refractory myeloma$

Novel agent opens up new treatment option for patients with refractory myeloma

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria participated.

6 Dec 2019

Researchers confirm two new prognostic markers for triple negative breast cancer

Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide.

5 Dec 2019

NeutroCure project aims to cure inflammatory disease with neutrophils

Curing disease with neutrophils; this is the goal of the NeutroCure project. How will that work? "Neutrophils have a yin yang character," explained Andrés Hidalgo, whose team at the Centro Nacional de Investigaciones Cardiovasculares is one of six member groups participating in this project coordinated by Andriy Mokhir Friedrich from Alexander University, Germany.

5 Dec 2019

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

5 Dec 2019

UPV researchers develop new methodology to monitor patients with glioblastoma

Glioblastoma is the most aggressive brain tumor in adults. Now, it can be treated with neurosurgery, radiotherapy and chemotherapy. Still, the median life expectancy of patients affected with this pathology is no longer than 15 months.

5 Dec 2019

More research funding needed to improve pancreatic cancer survival rates

Pancreatic cancer is the third deadliest form of the disease after lung cancer and colorectal cancer.

4 Dec 2019

Study highlights the need to adhere to more uniform diagnostic criteria for rare lymphoma

In what is believed to be one of the largest studies of a rare disorder known as primary cutaneous gamma delta T-cell lymphoma, Rutgers Cancer Institute of New Jersey investigators and other collaborators examined characteristics, treatment patterns and outcomes of the disease, and determined accurate diagnosis of the disease requires ongoing analysis.

4 Dec 2019

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.

4 Dec 2019

Michigan dermatologists honored for diagnosing rare condition

The American Academy of Dermatology has honored board-certified dermatologists Steven Daveluy, MD, FAAD, and Benjamin Workman, MD, FAAD, as Patient Care Heroes for their teamwork with oncologists to diagnose a rare condition affecting just one in a million patients, known as drug-induced hypersensitivity syndrome.

4 Dec 2019

Novel mathematical model could lead to more personalized treatments for cancer patients

Researchers have found a new way to use math to better treat cancer and prevent its relapse.

4 Dec 2019

Hybrid antibiotics show promising results in eradicating deadly staph infections

Eradicating deadly staph using a new breed of antibiotics has revealed promising results in research released by QUT, to help overcome one of the biggest modern medical challenges.

4 Dec 2019

Study identifies improved treatment option for neuroblastoma

Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, through genome sequencing, that the protein ALK and the cancer gene PIM1 are involved in the development of this tumor.

4 Dec 2019

New project could mark a pivotal advancement in therapies to address male sterility

Researchers from the University of Georgia, Emory University School of Medicine and the University of Pittsburgh have received a $2.9 million grant from the National Institutes of Health to test a novel method of producing viable sperm cells from skin cells.

3 Dec 2019

Newer safer way to effectively treat deadly brain cancer

A new engineering solution may help deliver tumor killing drugs directly to the brain tumor without the toxic body effects of systemic chemotherapy. The new study published in the journal Nature Scientific Reports reports on the use of coaxial electrospinning, an industrial fabrication technology, in the production of membranes that incorporate drugs to treat glioblastoma multiforme (GBM), an aggressive cancer of the brain.

3 Dec 2019

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Researchers identify key protein required for therapeutic resistance in aggressive breast cancer

Researchers at the Lady Davis Institute have identified a key protein that is required for resistance to chemotherapy in the most aggressive form of breast cancer. This holds the promise of opening the door to new therapies for overcoming drug resistance.

2 Dec 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

Important biomarker may help in determining prognosis of brain cancer patients

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Genetic features of AML in older patients can predict outcomes after stem cell transplant

Cancer in the eye does not always develop into central nervous system lymphoma

Novel agent opens up new treatment option for patients with refractory myeloma

Researchers confirm two new prognostic markers for triple negative breast cancer

NeutroCure project aims to cure inflammatory disease with neutrophils

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

UPV researchers develop new methodology to monitor patients with glioblastoma

More research funding needed to improve pancreatic cancer survival rates

Study highlights the need to adhere to more uniform diagnostic criteria for rare lymphoma

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Michigan dermatologists honored for diagnosing rare condition

Novel mathematical model could lead to more personalized treatments for cancer patients

Hybrid antibiotics show promising results in eradicating deadly staph infections

Study identifies improved treatment option for neuroblastoma

New project could mark a pivotal advancement in therapies to address male sterility

Newer safer way to effectively treat deadly brain cancer

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Researchers identify key protein required for therapeutic resistance in aggressive breast cancer

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in